BioPharma Dive - Latest News

Facing ‘uncertainty on steroids,’ biotech dealmakers tread more cautiously

Experts say market turmoil has made it harder for buyers and sellers to agree on price, which can be an especially imposing obstacle to large acquisitions.

May 6, 2025 - 17:16
 0
Facing ‘uncertainty on steroids,’ biotech dealmakers tread more cautiously

Experts say market turmoil has made it harder for buyers and sellers to agree on price, which can be an especially imposing obstacle to large acquisitions.

Read More

Tags:

Previous Article

Ineos charts future with dealer network revamp, powertrain pragmatism

Next Article

Synergy of phase and interface engineering of manganese difluoride enables high-...

Related Posts

Etiome, a new Flagship startup, looks to catch disease before it strikes

Etiome, a new Flagship startup, looks to catch disease ...

Apr 24, 2025  0

Caribou, in reversal, scraps autoimmune cell therapy and cuts staff

Caribou, in reversal, scraps autoimmune cell therapy an...

Apr 25, 2025  0

Bristol Myers says schizophrenia drug launch ‘off to a solid start’

Bristol Myers says schizophrenia drug launch ‘off to a ...

Apr 24, 2025  0